Shorepoint Capital Partners LLC Reduces Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Shorepoint Capital Partners LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 37.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,633 shares of the healthcare conglomerate's stock after selling 3,312 shares during the period. Shorepoint Capital Partners LLC's holdings in UnitedHealth Group were worth $2,850,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Howard Capital Management Group LLC bought a new stake in UnitedHealth Group in the third quarter valued at approximately $341,000. Principal Financial Group Inc. lifted its holdings in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after buying an additional 180,479 shares during the period. McIlrath & Eck LLC grew its holdings in UnitedHealth Group by 8.2% during the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock worth $371,000 after acquiring an additional 48 shares during the period. SOA Wealth Advisors LLC. lifted its stake in shares of UnitedHealth Group by 3.7% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock valued at $746,000 after purchasing an additional 46 shares during the period. Finally, Tudor Financial Inc. bought a new stake in UnitedHealth Group in the third quarter worth approximately $900,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the subject of several research analyst reports. KeyCorp lowered their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Truist Financial cut their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday, April 21st. Royal Bank of Canada dropped their price target on UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Hsbc Global Res downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 22nd. Finally, Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Buy" and a consensus price target of $596.86.

UnitedHealth Group Stock Performance

UNH traded down $2.25 during trading on Friday, hitting $398.44. 7,547,223 shares of the company traded hands, compared to its average volume of 4,583,871. The firm has a market cap of $362.67 billion, a P/E ratio of 25.70, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $393.31 and a one year high of $630.73. The stock's fifty day moving average is $497.29 and its 200 day moving average is $529.82.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the firm posted $6.91 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. UnitedHealth Group's dividend payout ratio is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.